Prophylactic antibiotic therapy in chronic obstructive pulmonary disease

Area of Science:

• Pulmonary Medicine
• Infectious Diseases
• Microbiology

Background:

• Chronic obstructive pulmonary disease (COPD) presents a significant global health challenge, marked by persistent inflammation and bacterial presence.
• This chronic bacterial colonization exacerbates inflammation and damages lung epithelium, increasing susceptibility to acute infections and exacerbations.
• Acute exacerbations are primary drivers of COPD hospitalizations and lead to irreversible declines in lung function.

Purpose of the Study:

• To review current literature on the use of antibiotic prophylaxis in stable COPD.
• To evaluate the potential benefits of breaking the cycle of chronic bacterial colonization and inflammation.
• To address the controversial role and limited evidence regarding long-term antibiotic use in non-exacerbated COPD patients.

Main Methods:

• Literature review of existing studies on antibiotic prophylaxis in stable COPD.
• Analysis of recent data concerning bacterial colonization, inflammation, and epithelial damage in COPD.
• Focus on evidence addressing the theoretical benefits versus clinical data for long-term antibiotic use.

Main Results:

• The role of antibiotic prophylaxis in stable COPD remains controversial.
• Theoretical benefits include interrupting the cycle of chronic inflammation and bacterial colonization.
• Robust clinical evidence supporting its routine use in stable COPD is currently scarce.

Conclusions:

• Antibiotic prophylaxis in stable COPD is theoretically appealing for managing chronic inflammation and bacterial colonization.
• Further high-quality research is needed to establish the efficacy and safety of long-term antibiotic use in this patient population.
• The dilemma between theoretical benefit and limited evidence highlights the need for careful consideration in clinical practice.